Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study

Liu, Fuquan; Ning, Zhenyuan; Liu, Yanna; Liu, Dengxiang; Tian, Jie; Luo, Hong-wu; An, W.; Huang, Yifei; Zou, Jialiang; Liu, Chuan; Liu, Changchun; Wang, Lei; Liu, Zaiyi; Qi, Ruizhao; Zuo, Changzeng; Zhang, Qingge; Wang, Jitao; Zhao, Dawei; Duan, Y.; Peng, Baogang; Qi, X.; Zhang, Yuening; Yang, Yongping; Hou, J.; Dong, Jiahong; Li, Zhiwei; Ding, Huiguo; Zhang, Yu; Qi, Xianghui

doi:10.1016/j.ebiom.2018.09.023

Public

Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study

Published in EBioMedicine • Sep 27, 2018

Authors:

Fuquan Liu

Zhenyuan Ning

Yanna Liu

Abstract

Clinically significant portal hypertension (CSPH) is associated with an incremental risk of esophageal varices and overt clinical decompensations. However, hepatic venous pressure gradient (HVPG) measurement, the gold standard for defining CSPH (HVPG≥10 mm Hg) is invasive and therefore not suitable ...

View

Open Access

Subject

Medicine

Generate AI Take for this paper

Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!